Hydroxychloroquine Sulfate Accord-Uk

Hydroxychloroquine, the active ingredient in Hydroxychloroquine Sulfate Accord-Uk, is an antimalarial presented as an oral tablet for oral use. It is employed to treat malaria, rheumatoid arthritis, and systemic lupus erythematosus in suitable patients, acting on intracellular parasites and modulating immune responses.

GNH USA supplies Hydroxychloroquine Sulfate Accord-Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution. The product complies with EU pharmacopeial specifications and is suitable for export to regulated markets.

Hydroxychloroquine is an antimalarial agent used to manage infections and autoimmune disorders, offering therapeutic benefits in